Abstract:Cerebral amyloid angiopathy (CAA) is recognized as a cause of cognitive impairment, but its cognitive profile needs to be characterized, also respect to hypertension-related microangiopathy (HA). We aimed at comparing difference or similarity of CAA and HA patients' cognitive profiles, and their associated factors. Participants underwent an extensive clinical, neuropsychological, and neuroimaging protocol. HA patients (n = 39) were more frequently males, with history of vascular risk factors than CAA (n = 32). Compared to HA, CAA patients presented worse performance at MoCA (p = 0.001) and semantic fluency (p = 0.043), and a higher prevalence of amnestic MCI (46% vs. 68%). In univariate analyses, multi-domain MCI was associated with worse performance at MoCA, Rey Auditory Verbal Learning Test (RAVLT), and semantic fluency in CAA patients, and with worse performance at Symbol Digit Modalities Test (SDMT) and phonemic fluency in HA ones. In multivariate models, multi-domain deficit remained as the only factor associated with RAVLT (β = − 0.574) in CAA, while with SDMT (β = − 0.364) and phonemic fluency (β = − 0.351) in HA. Our results highlight different patterns of cognitive deficits in CAA or HA patients. While HA patients' cognitive profile was confirmed as mainly attentional/executive, a complex cognitive profile, characterized also by deficit in semantic memory, seems the hallmark of CAA patients.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to compare the differences in cognitive characteristics and their associated factors between patients with two main types in cerebral small - vessel disease (cSVD), namely cerebral amyloid angiopathy (CAA) and hypertension - related microangiopathy (HA). Specifically, the study aims to: 1. **Compare the cognitive characteristics of patients with CAA and HA**: Through detailed clinical, neuropsychological and neuroimaging evaluations, explore the similarities and differences in cognitive performance between these two diseases. 2. **Analyze the relationship between cognitive characteristics and clinical and functional characteristics**: Through statistical analysis, determine which factors are related to specific patterns of cognitive deficits. ### Research Background - **Cerebral small - vessel disease (cSVD)**: It is a set of pathological processes that affect the small blood vessels in the brain (such as arterioles, venules, capillaries, etc.). cSVD may lead to lesions such as white matter hyperintensities (WMH), lacunes, cerebral microbleeds (CMBs), enlarged perivascular spaces (EPVS) and microinfarcts, which may cause a gradual deterioration of cognition, function and motor ability. - **Cerebral amyloid angiopathy (CAA)**: It is mainly manifested as β - amyloid deposition in the walls of small arteries in the cerebral cortex and leptomeninges, resulting in dilation, rupture of the vessel walls and blood extravasation. - **Hypertension - related microangiopathy (HA)**: It is mainly manifested as sclerosis of small perforating arteries, and is usually related to vascular risk factors such as hypertension, smoking and type 2 diabetes. ### Research Objectives - **Comparison of cognitive characteristics**: Through neuropsychological tests, compare the performance of patients with CAA and HA in different cognitive domains, such as global cognitive function, verbal memory, executive function, attention and information processing speed. - **Associated factors of multi - domain cognitive impairment**: Through univariate and multivariate analyses, explore the relationship between multi - domain cognitive impairment and specific clinical and functional characteristics. ### Main Findings - **Patients with CAA**: - Poorer global cognitive function (MoCA score). - Poorer performance in semantic fluency tasks. - Multi - domain mild cognitive impairment (multi - domain MCI) is related to poorer immediate and delayed recall (RAVLT) and poorer performance in semantic fluency tasks. - Functional status (IADL and ADL) is related to poorer global cognitive efficiency, verbal memory and poorer performance in semantic fluency tasks. - **Patients with HA**: - Non - amnestic mild cognitive impairment (non - amnestic MCI) is more common. - Multi - domain cognitive impairment is related to poorer performance in the Symbol Digit Modalities Test (SDMT) and phonemic fluency tasks. - Depressive symptoms are related to poorer global cognitive efficiency (MoCA score). ### Conclusions - **Cognitive characteristics of patients with CAA**: It is manifested as more complex multi - domain cognitive impairment, including a decline in verbal memory and semantic processing ability, as well as impairment of executive function, attention and information processing speed. - **Cognitive characteristics of patients with HA**: It is mainly manifested as non - amnestic mild cognitive impairment, and cognitive deficits are concentrated in attention and executive function. - **Influence of functional status**: In patients with CAA, functional status is closely related to cognitive performance, while in patients with HA, depressive symptoms have a significant impact on cognitive performance. Through these findings, the study further emphasizes the differences in cognitive characteristics between patients with CAA and HA, providing an important reference for clinical diagnosis and treatment.

Cognitive profile in cerebral small vessel disease: comparison between cerebral amyloid angiopathy and hypertension-related microangiopathy

Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment

Cognitive and psychological characteristics in patients with Cerebral Amyloid Angiopathy: a literature review

Cognition in (pre)symptomatic Dutch‐type hereditary and sporadic cerebral amyloid angiopathy

Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy

Abstract WMP14: Cerebrospinal Fluid Beta-Amyloid Concentration and MRI Manifestations of Cerebral Amyloid Angiopathy

The clinical profile of cerebral small vessel disease: Toward an evidence‐based identification of cognitive markers

CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy

Glymphatic dysfunction correlates with severity of small vessel disease and cognitive impairment in cerebral amyloid angiopathy

Clinical characteristics of cerebral amyloid angiopathy and risk factors of cerebral amyloid angiopathy related intracerebral hemorrhage

Non‐hemorrhagic imaging markers of cerebral amyloid angiopathy in memory clinic patients

Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross-sectional study

Subcortical volumes in cerebral amyloid angiopathy compared with Alzheimer's disease and controls

The Association Between Hypertensive Angiopathy and Cerebral Amyloid Angiopathy in Primary Intracerebral Hemorrhage

Differences in the cerebral amyloid angiopathy proteome in Alzheimer's disease and mild cognitive impairment

Neuropsychiatric symptoms and lifelong mental activities in cerebral amyloid angiopathy - a cross-sectional study

Capillary cerebral amyloid angiopathy in Alzheimer's disease: association with allocortical/hippocampal microinfarcts and cognitive decline

Peak width of skeletonized mean diffusivity in cerebral amyloid angiopathy: Spatial signature, cognitive, and neuroimaging associations

Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates

Cognitive impairment and amygdala subregion volumes in elderly with cerebral small vessel disease: A large prospective cohort study

Cerebral Microbleeds, Cerebral Amyloid Angiopathy, and Their Relationships to Quantitative Markers of Neurodegeneration